BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21252084)

  • 1. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
    Wilkins MR; Khan S; Bunce C; Khawaja A; Siriwardena D; Larkin DF
    Br J Ophthalmol; 2011 Sep; 95(9):1299-303. PubMed ID: 21252084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
    Wong AC; Mak ST
    Br J Ophthalmol; 2012 Jul; 96(7):1040-1. PubMed ID: 22053100
    [No Abstract]   [Full Text] [Related]  

  • 4. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
    Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
    Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
    Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
    Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
    Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of adenovirus strains isolated from patients with acute conjunctivitis in the city of São Paulo, Brazil.
    Tanaka K; Itoh N; Saitoh-Inagawa W; Uchio E; Takeuchi S; Aoki K; Soriano E; Nishi M; Júnior RB; Hársi CM; Tsuzuki-Wang L; Durigon EL; Stewien KE; Ohno S
    J Med Virol; 2000 May; 61(1):143-9. PubMed ID: 10745247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo.
    Inoue H; Sonoda KH; Ishikawa M; Kadonosono K; Uchio E
    Ophthalmologica; 2009; 223(4):233-8. PubMed ID: 19262070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.
    Toker MI; Erdem H; Erdogan H; Arici MK; Topalkara A; Arslan OS; Pahsa A
    Am J Ophthalmol; 2006 May; 141(5):902-905. PubMed ID: 16527227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of high dose dexamethasone in the treatment of acute stroke.
    Ogun SA; Odusote KA
    West Afr J Med; 2001; 20(1):1-6. PubMed ID: 11505880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of 1 versus 3 days of dexamethasone as add-on therapy in children with streptococcal pharyngitis.
    Niland ML; Bonsu BK; Nuss KE; Goodman DG
    Pediatr Infect Dis J; 2006 Jun; 25(6):477-81. PubMed ID: 16732143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two clinical trials of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Wong V
    Trans Am Ophthalmol Soc; 1999; 97():261-74; discussion 274-9. PubMed ID: 10703128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.
    Shiuey Y; Ambati BK; Adamis AP
    Ophthalmology; 2000 Aug; 107(8):1512-7. PubMed ID: 10919900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.